STOK CIK: 1623526

Stoke Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.9
FY22:
−31.9
FY23:
−81.1
FY24:
−86.9
FY25:
45.6
Change from FY21 to FY25
millions USD
FY21:
−76.4
FY22:
−45.9
FY23:
106
FY24:
−107
FY25:
−187
Change from FY21 to FY25
millions USD
FY21:
1.28
FY22:
46.4
FY23:
53.0
FY24:
131
FY25:
97.4
millions USD
FY21:
−142
FY22:
−31.3
FY23:
77.9
FY24:
−63.2
FY25:
−43.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−68.1
FY22:
−35.8
FY23:
−82.7
FY24:
−87.1
FY25:
44.9

All amounts in millions USD Data source:SEC EDGAR